Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- ADA (1)
- Advance directives (1)
- Bioethics (1)
- Consent (1)
- Decision-making (1)
-
- Discrimination (1)
- Doctors (1)
- End of life (1)
- Health and medical research (1)
- Health care finance and delivery system (1)
- Health care services (1)
- Health insurance (1)
- Individuals with disabilities (1)
- Information (1)
- Informed consent (1)
- Living wills (1)
- Medical treatment (1)
- Patients (1)
- Regulation (1)
Articles 1 - 3 of 3
Full-Text Articles in Law
The Best-Laid Plans, Carl E. Schneider
The Best-Laid Plans, Carl E. Schneider
Articles
It is natural to suppose law is like the centurion and can do as it will: "I say to this man, Go, and he goeth; and to another, Come, and he cometh; and to my servant, Do this, and he doeth it." But a thousand years ago, King Canute tried to disillusion his courtiers about his efficacy by commanding the waves to stop beating. And fifty years ago, Harry Truman predicted of Dwight Eisenhower, "He'll sit here, and he'll say, 'Do this! Do that!' And nothing will happen. Poor Ike-it won't be a bit like the Army. He'll find it …
Becoming Visible: The Ada's Impact On Healthcare For Persons With Disabilities, Mary Crossley
Becoming Visible: The Ada's Impact On Healthcare For Persons With Disabilities, Mary Crossley
Articles
This Article will adopt the perspective of individuals with disabilities in their encounters with the health care finance and delivery system in the United States, and will pose the question of what the past decade has shown the ADA to mean (or not mean) for those individuals' ability to seek, receive, and pay for effective health care services. To that end, this Article will provide an overview of three broad areas on which the ADA has had varying degrees of impact.
Part II of the Article will examine how the ADA has affected the rights of an individual with a …
Financing Clinical Research And Experimental Therapies: Payment Due, But From Whom?, Patricia C. Kuszler
Financing Clinical Research And Experimental Therapies: Payment Due, But From Whom?, Patricia C. Kuszler
Articles
This article will explore the realm of clinical research and the question of who should finance such research. The first part will define the various types and levels of clinical research in terms of the regulatory controls and oversight applied to such research. Then the article will summarize how the costs of clinical research and experimental therapies have been covered in the past. Finally, the article will evaluate the risks and benefits derived by the various stakeholders and propose a financing rationale for therapies that places the burden of cost squarely on the stakeholders most likely to benefit.